{"transactions":[{"id":1117555,"issuer":{"id":6086,"kind":"organization","name":"ANAVEX LIFE SCIENCES CORP.","symbol":"AVXL"},"owners":[{"id":78717,"kind":"person","name":"Thomas Steffen","position":1,"cik":"0001646396","reported_name":"Thomas Steffen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-09T21:30:47.000Z","date":"2025-06-05","kind":"exercise","planned":false,"acquired":false,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vested in three equal annual installments beginning on June 15, 2016"}],"balance_after":0,"derivative":{"exercise_price":1.76,"expiration_date":"2025-06-15","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001731122-25-000837","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1314052/000173112225000837/ownership.xml","form_type":"4"}},{"id":1117554,"issuer":{"id":6086,"kind":"organization","name":"ANAVEX LIFE SCIENCES CORP.","symbol":"AVXL"},"owners":[{"id":78717,"kind":"person","name":"Thomas Steffen","position":1,"cik":"0001646396","reported_name":"Thomas Steffen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2025-06-09T21:30:47.000Z","date":"2025-06-05","kind":"tax_withholding","planned":false,"acquired":false,"shares":11349,"price":7.75,"value":87954.75,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a \"net exercise\" of outstanding stock options, which options were scheduled to expire on June 15, 2025. The reporting person received 38,651 shares of common stock on net exercise of an option to purchase 50,000 shares of common stock. The Company withheld 11,349 shares of common stock underlying the option as consideration for the exercise price, using the average of the high and low sales price on June 5, 2025 of $7.75, pursuant to the terms of the Company's 2007 Stock Option Plan."}],"balance_after":43651,"source":{"system":"sec-edgar","filing":"0001731122-25-000837","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1314052/000173112225000837/ownership.xml","form_type":"4"}},{"id":1117553,"issuer":{"id":6086,"kind":"organization","name":"ANAVEX LIFE SCIENCES CORP.","symbol":"AVXL"},"owners":[{"id":78717,"kind":"person","name":"Thomas Steffen","position":1,"cik":"0001646396","reported_name":"Thomas Steffen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2025-06-09T21:30:47.000Z","date":"2025-06-05","kind":"exercise","planned":false,"acquired":true,"shares":50000,"price":1.76,"value":88000.0,"ownership":{"direct":true},"balance_after":55000,"source":{"system":"sec-edgar","filing":"0001731122-25-000837","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1314052/000173112225000837/ownership.xml","form_type":"4"}},{"id":1182852,"issuer":{"id":6086,"kind":"organization","name":"ANAVEX LIFE SCIENCES CORP.","symbol":"AVXL"},"owners":[{"id":78717,"kind":"person","name":"Thomas Steffen","position":1,"cik":"0001646396","reported_name":"Thomas Steffen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-04-03T01:45:40.000Z","date":"2025-03-31","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in three equal annual installments beginning on March 31, 2026"}],"balance_after":50000,"derivative":{"exercise_price":8.58,"expiration_date":"2035-03-31","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001731122-25-000515","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1314052/000173112225000515/ownership.xml","form_type":"4"}},{"id":1510841,"issuer":{"id":6086,"kind":"organization","name":"ANAVEX LIFE SCIENCES CORP.","symbol":"AVXL"},"owners":[{"id":78717,"kind":"person","name":"Thomas Steffen","position":1,"cik":"0001646396","reported_name":"Thomas Steffen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-17T10:01:00.000Z","date":"2024-05-15","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":4.52,"value":22600.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Purchase price denominated in Euros has been translated to US dollars using an exchange rate of 0.92"}],"balance_after":5000,"source":{"system":"sec-edgar","filing":"0001731122-24-000828","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1314052/000173112224000828/ownership.xml","form_type":"4"}},{"id":1622131,"issuer":{"id":6086,"kind":"organization","name":"ANAVEX LIFE SCIENCES CORP.","symbol":"AVXL"},"owners":[{"id":78717,"kind":"person","name":"Thomas Steffen","position":1,"cik":"0001646396","reported_name":"Thomas Steffen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-02-23T11:04:32.000Z","date":"2024-02-20","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options vest in equal installments over three years from the grant date."}],"balance_after":50000,"derivative":{"exercise_price":5.36,"exercise_date":"2025-02-20","expiration_date":"2034-02-20","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001731122-24-000295","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1314052/000173112224000295/ownership.xml","form_type":"4"}},{"id":1927248,"issuer":{"id":6086,"kind":"organization","name":"ANAVEX LIFE SCIENCES CORP.","symbol":"AVXL"},"owners":[{"id":78717,"kind":"person","name":"Thomas Steffen","position":1,"cik":"0001646396","reported_name":"Thomas Steffen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-04-04T21:31:15.000Z","date":"2023-03-31","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options vest in equal instalments over three years from the grant date"}],"balance_after":50000,"derivative":{"exercise_price":8.57,"exercise_date":"2024-03-31","expiration_date":"2033-03-31","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001731122-23-000584","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1314052/000173112223000584/ownership.xml","form_type":"4"}},{"id":2219257,"issuer":{"id":6086,"kind":"organization","name":"ANAVEX LIFE SCIENCES CORP.","symbol":"AVXL"},"owners":[{"id":78717,"kind":"person","name":"Thomas Steffen","position":1,"cik":"0001646396","reported_name":"Thomas Steffen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-29T21:14:43.000Z","date":"2022-06-27","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":50000,"derivative":{"exercise_price":10.09,"exercise_date":"2023-06-27","expiration_date":"2032-06-27","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001731122-22-001147","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1314052/000173112222001147/ownership.xml","form_type":"4"}},{"id":2614485,"issuer":{"id":6086,"kind":"organization","name":"ANAVEX LIFE SCIENCES CORP.","symbol":"AVXL"},"owners":[{"id":78717,"kind":"person","name":"Thomas Steffen","position":1,"cik":"0001646396","reported_name":"Thomas Steffen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-08-04T21:26:04.000Z","date":"2021-08-02","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":25000,"derivative":{"exercise_price":18.11,"exercise_date":"2022-08-02","expiration_date":"2031-08-02","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001731122-21-001296","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1314052/000173112221001296/ownership.xml","form_type":"4"}},{"id":2925167,"issuer":{"id":6086,"kind":"organization","name":"ANAVEX LIFE SCIENCES CORP.","symbol":"AVXL"},"owners":[{"id":78717,"kind":"person","name":"Thomas Steffen","position":1,"cik":"0001646396","reported_name":"Thomas Steffen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-01-04T19:28:17.000Z","date":"2020-12-30","kind":"grant","acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":35000,"derivative":{"exercise_price":5.49,"exercise_date":"2021-12-30","expiration_date":"2030-12-30","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001731122-21-000014","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1314052/000173112221000014/ownership.xml","form_type":"4"}},{"id":3315202,"issuer":{"id":6086,"kind":"organization","name":"ANAVEX LIFE SCIENCES CORP.","symbol":"AVXL"},"owners":[{"id":78717,"kind":"person","name":"Thomas Steffen","position":1,"cik":"0001646396","reported_name":"Thomas Steffen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-01-08T23:00:23.000Z","date":"2020-01-06","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":50000,"derivative":{"exercise_price":2.96,"exercise_date":"2021-01-06","expiration_date":"2030-01-06","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001731122-20-000022","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1314052/000173112220000022/ownership.xml","form_type":"4"}},{"id":3798142,"issuer":{"id":6086,"kind":"organization","name":"ANAVEX LIFE SCIENCES CORP.","symbol":"AVXL"},"owners":[{"id":78717,"kind":"person","name":"Thomas Steffen","position":1,"cik":"0001646396","reported_name":"Thomas Steffen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-10-03T21:30:36.000Z","date":"2018-10-01","kind":"grant","acquired":true,"shares":45500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options shall vest upon the achievement of 50% enrollment in the Company's Alzheimer's disease and Parkinson's disease dementia clinical trials."}],"balance_after":45500,"derivative":{"exercise_price":2.58,"expiration_date":"2028-10-01","underlying":"Common Stock","underlying_shares":45500},"source":{"system":"sec-edgar","filing":"0001615774-18-010441","document":"s113105_form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1314052/000161577418010441/s113105_form4.xml","form_type":"4"}},{"id":4594968,"issuer":{"id":6086,"kind":"organization","name":"ANAVEX LIFE SCIENCES CORP.","symbol":"AVXL"},"owners":[{"id":78717,"kind":"person","name":"Thomas Steffen","position":1,"cik":"0001646396","reported_name":"Thomas Steffen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2016-09-26T21:18:28.000Z","date":"2016-09-22","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":100000,"derivative":{"exercise_price":3.28,"exercise_date":"2016-09-22","expiration_date":"2026-09-22","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001615774-16-007384","document":"s104216_form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1314052/000161577416007384/s104216_form4.xml","form_type":"4"}}]}